BACKGROUND AND OBJECTIVES: late onset sepsis (los)( onset of sepsis >72 hours of age or nosocomial sep--sis) is an important cause of morbidity and mortality in the neonatal intensive care unit (nicu). thrombocytopenia is an important complication of sepsis. We investigated the incidence of thrombocytopenia in los patients and studied the influence of various parameters on platelet response. PATIENTS AND METHODS: infants born in the level 3 neonatal intensive care unit between January 2002 and december 2006 with documented los were included in this prospective study. multiple hemograms with platelet counts, bacterial blood culture and fungal blood culture were obtained in all patients. demographic and clinical data were compared between patients without thrombocytopenia and with mild, moderate and severe thrombocytopenia. duration of thrombocytopenia in relation to type of organism and mortality with respect to degree of thrombocytopenia were also studied. RESULTS: of 200 patients with culture-proven nosocomial sepsis, 119 (59.5%) patients developed thrombocyto--penia (platelet count <150×10 9 /l). in our series Klebsiella pneumoniae was the most frequently isolated organism (125/200, 62.5%) and the incidence of thrombocytopenia was 60.0% (75/125). however, the incidence of thrombo--cytopenia was highest among patients who had concurrent bacterial and fungal sepsis (28/31, 90.3%). coagulasenegative staphylococcal (cons) sepsis was present in 21 (10.5%) patients and the incidence of thrombocytopenia was 33.3%. isolated fungal sepsis was present only in 6 (3%) patients and the incidence of thrombocytopenia was 66.0%. the incidence of thrombocytopenia was highest among preterm babies and low-birth weight (lbW) babies. twenty-seven percent (54/200) of babies presented with mild thrombocytopenia, 20% (40/200) presented with moderate thrombocytopenia, and 12.5%(25/200) developed severe thrombocytopenia. severity of thrombocyto--penia was also directly related to the presence of necrotizing enterocolitis (nec) and disseminated intravascular coagulation (dic). the mortality rate was significantly associated with the degree of thrombocytopenia. CONCLUSION: los sepsis is an important risk factor for thrombocytopenia in the nicu. fungal and gramnegative sepsis are frequently associated with a decreased platelet count. sepsis-induced thrombocytopenia is more common among lbW babies and preterm babies. the mortality rate is significantly related to degree of thrombocytopenia.
birth weight (ELBW) babies (birth weight <1000 g). 2 Thrombocytopenia is an important complication of sepsis and can occur in 25% of patients admitted in the NICU. 3 Early-onset thrombocytopenia develops in utero or within 72 hours of birth and has a varied etiology; late-onset thrombocytopenia is almost al--ways caused by sepsis and necrotizing enterocolitis. incidence of thrombocytopenia in gram-negative septi--cemia and 65% incidence in gram-positive septicemia. In recent years fungal sepsis is increasingly associated with thrombocytopenia, especially in ELBW babies.6 A fall in the platelet count is an early marker of sep--sis and in fact can be used as a screening procedure for early detection of sepsis, especially in NICU settings.
We designed a prospective study with the aim of learning the incidence of thrombocytopenia in bloodculture positive sepsis and to study the influence of pa--rameters like birthweight, gestational age and sepsisassociated comorbidities like necrotizing enterocolitis (NEC) and disseminated intravascular coagulation (DIC) on platelet response. The duration of thrombo--cytopenia in relation to type of organism and mortal--ity with respect to degree of thrombocytopenia were also studied.
PATIENTS AND METHODS
The study was performed prospectively in the neonatol--ogy unit of the Sher-I-Kashmir Institute Of Medical Sciences (SKIMS), which is a tertiary care centre, from January 2002 to December 2006 with prior approval by hospital ethical committee. Two hundred infants were included. All the babies were born in-house. An eligibil--ity criterion was the presence of documented nosocomial LOS, defined by the presence of clinical features of sep--sis along with a positive blood culture. Coagulase-nega--tive staphylococcal (CoNS) sepsis was defined in our study as clinical signs of sepsis with a minimum of two positive blood cultures. For all patients in the nursery, it is our policy to do a routine baseline workup, which in--cludes complete blood count (CBC), C-reactive protein (CRP) estimation, bacterial blood culture and fungal culture. Babies with early onset thrombocytopenia were excluded from the study. Infants with symptoms of sep--sis (respiratory distress, poor feeding, lethargy, shock, disseminated intravascular coagulation, temperature instability) had a repeat sepsis evaluation performed. The evaluation CoNSisted of a CBC, including plate--let indices, blood culture (bacterial and fungal), and serial CRP estimation. In case of clinical bleeding co--agulogram with d-dimer ELISA was performed. Blood samples were drawn from peripheral venous puncture or through a central catheter. CBCs were performed by using Coulter counter (Sismax ST 3000). Serial platelet counts were performed in thrombocytopenic patients until platelet counts were normalized. Relevant data like sex, gestational age, birth weight, antenatal history, history of pregnancy-induced hypertension (PIH), mode of delivery, Apgar score, and hospital stay were recorded in all the study patients. Thrombocytopenia was defined as a platelet count of < 150×10 9 /L and was classified by severity (mild if the platelet count was be--tween 100 and <150×10 9 /L, moderate if the count was between 50 and <100×10 9 /L, and severe if the platelet count nadir was <50 ×10 9 /L). Mortality was defined as death before discharge. Infants who were discharged to home were categorized as survivors.
Data is expressed as mean and standard deviation, and percentages. The intergroup comparison was done by the t test and ANOVA (F-test).
RESULTS
Two hundred cases of nosocomial sepsis were identi--fied. Thrombocytopenia developed in 119 (59.5%) patients. Among the thrombocytopenic patients, 54 (27%) were diagnosed as mild, 40 (20%) as moderate, and 25 (12.5%) as severe.
We compared neonatal data between the patients without thrombocytopenia and with mild, moder--ate and severe thrombocytopenia ( [3.16] weeks) (P<.01). However, the dif--ference in gestational age and birth weight between the patients with no thrombocytopenia and mild thrombo--cytopenia was insignificant (P>.05).
The incidence of NEC was more in patients with severe thrombocytopenia (6/25, 24%) and moder--ate thrombocytopenia (8/40, 20%) than in patients with mild thrombocytopenia (1/54, 5.90%), and no thrombocytopenia (2/81, 11.80%). (P<.01). Similarly DIC was more commonly found in patients with se--vere thrombocytopenia (22/25, 88.0%) and moderate thrombocytopenia (10/40, 25.0%) (P<.01). Mortality was significantly more in patients with DIC. The pres--ence of DIC among survivors was 17/159 versus nonsurvivors 19/41, P<.01). No differences were observed in maternal age, parity, gender, mode of delivery, Apgar score, or TORCH positivity among the groups.
Of the 200 patients with documented nosocomial sepsis, 125 (62.5%) were infected with Klebsiella pneu--moniae and 75 (60.0%) developed thrombocytopenia ( (P<.01). The incidence of CoNS sepsis in our study population was 10.5% (21/200) and among these 7 (33.3%) patients had at least 1 episode of thrombo--cytopenia. Six patients (3%) in our series had a posi--tive culture for Candida albicans, and the incidence of thrombocytopenia in those patients was 66.6% (4/6). All were ELBW babies. Other organisms isolated were E coli (5/200, 2.5%), S aureus (7/200, 3.5%) and Enterococcus (5/200, 2.5%).
The mean duration of thrombocytopenia was signifi--cantly higher in patients of combined bacterial and fun--gal sepsis (P<.05) as compared to isolated fungal sepsis and Klebsiella sepsis. The mean duration of thrombocy--topenia was lowest in CoNS sepsis (Figure 1) .
The overall mortality rate in our study population was 20.5% (41/200) (Figure 2 
DISCUSSION
Platelets are among the least studied cells in sepsis, yet it has been well described for more than 30 years that patients with sepsis often have low platelet counts and that intravenous injection of lipopolysaccharides (LPS) into mice induces rapid thrombocytopenia. 7 Within a few minutes of the intravenous injection of lipopolysaccharide (LPS) into mice, platelets accumu--late primarily in the liver and in lungs. 8 Although the mechanisms of activation and recruitment remain un--clear, they are thought to be related to the cascade of endogenous mediators released rather than to a direct response to LPS.
We conducted this study to see the incidence of late-onset thrombocytopenia among inborn babies with documented nosocomial sepsis irrespective of ges-- tational age and birth weight. We observed that 59.5% of babies with documented sepsis developed a platelet count <150×10 9 /L with 27% presenting with mild, 20% moderate and 12% with severe thrombocytopenia. LOS is an important risk factor for thrombocytopenia and can involve up to 80% of septic babies. 9 In a study by Naeme et al 10 on adult patients, thrombocytopenia occurred in about 75% of patients. Furthermore, we observed that the incidence of thrombocytopenia was more common in LBW babies (67.1%) as compared to normal birth weight babies (48.1%, P<.05). The former group developed a lower platelet nadir. This was similar to observation of many authors. 11, 12 Profound thrombocytopenia occurs in humans with sepsis and in mice administered LPS. Growing evidence indicates that, in addition to their hemostatic role, platelets play an important role in linking innate and adaptive immune responses. 13 Platelets express a family of signaling receptors, known as Toll-like recep--tors (TLRs) and they recognize a variety of molecular structures found on bacteria, viruses, and fungi. [14] [15] [16] Recognition of these "danger" molecules leads to TLR signaling, which in turn leads to the production of sev--eral proinflammatory cytokines. 17 It appears that TLRs are sentinels of the innate immune system and are es--sential for the eventual stimulation of adaptive immu--nity against invading microorganisms. TLR expression on platelets has a role to play during infectious inflam--mation and atherosclerotic vascular disease. This is per--haps best exemplified by the clinical observation of se--vere thrombocytopenia associated with sepsis. 18 Some septic babies also develop thrombocytopenia on the ba--sis of DIC, but most have thrombocytopenia without laboratory evidence of DIC. In a study of septic adults by Naeme et al,10 DIC was present in a small minority, and these were a subgroup who had a platelet count of less than 50 000/L. Our data revealed that DIC was as--sociated in almost 25% of patients and the majority of them belonged to severe thrombocytopenia group.
NEC is an important risk factor for late-onset throm--bocytopenia. Ververidis et al 19 showed that thrombocy--topenia was a common finding in NEC. We confirmed the same association. The incidence of NEC was signifi--cantly higher in patients with moderate (20%) and se--vere thrombocytopenia (24%). We demonstrated an as--sociation of fungal sepsis and gram negative (Klebsiella) sepsis with thrombocytopenia, an association that has been confirmed in many studies. 20 In fact, we observed that the incidence of thrombocytopenia was highest among the patients with combined fungal and bacterial sepsis (90.3%) (most of whom had Klebsiella isolated from blood), followed by isolated fungal sepsis (66.6%) and Klebsiella sepsis (60.0%). CoNS sepsis was less fre--quently associated with thrombocytopenia in our series (33.3%). Padovani et al 21 reported 26 VLBW neonates who had fungal sepsis and noted that 19 (73%) present--ed with thrombocytopenia. In fact, it is recommended to start empiric antifungal treatment when thrombocy--topenia is seen in ELBW infants who are clinically septic with a nosocomial infection while awaiting culture re--ports. 22 Similarly, gram-negative sepsis is an important cause of thrombocytopenia in humans.
Thrombocytopenia is itself associated with increased mortality in neonates 23, 24 as well as in adult septic pa--tients. 25 We observed that morality was significantly more common in thrombocytopenic patients (26.8%) than patients with a normal platelet count (11.1%) (P<.01). Mortality was higher among patients with se--vere thrombocytopenia.
Our study indicates that a large proportion (59.5%) of infants with nosocomial sepsis develop thrombo--cytopenia and the severity of thrombocytopenia is di--rectly related to gestational age and birth weight. We were able to confirm that mixed fungal and bacterial sepsis were more frequently associated with thrombo--cytopenia with a significantly higher mean duration of thrombocytopenia. We demonstrated a significantly higher mortality in thrombocytopenic group than in the non-thrombocytopenic group. A larger controlled study could be undertaken in resource poor settings where the burden of sepsis and low birth weight is high, to test whether profound and persistent thrombocyto--penia can be used as a surrogate marker for fungal sep--sis. The study also gives some justification for empiric antifungal therapy in situations where fungal cultures are unavailable or unaffordable.
REFERENCES

